Tudor Investment Corp’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,236
| Closed | -$213K | – | 2243 |
|
|
2021
Q3 | $213K | Sell |
1,236
-19,467
| -94% | -$3.35M | ﹤0.01% | 1413 |
|
|
2021
Q2 | $2.6M | Buy |
+20,703
| New | +$2.6M | 0.05% | 430 |
|
|
2019
Q4 | – | Sell |
-13,649
| Closed | -$539K | – | 1445 |
|
|
2019
Q3 | $539K | Buy |
+13,649
| New | +$539K | 0.02% | 686 |
|
|
2018
Q1 | – | Sell |
-8,297
| Closed | -$352K | – | 1322 |
|
|
2017
Q4 | $352K | Sell |
8,297
-71,165
| -90% | -$3.02M | 0.01% | 748 |
|
|
2017
Q3 | $2.97M | Buy |
79,462
+66,662
| +521% | +$2.49M | 0.08% | 143 |
|
|
2017
Q2 | $389K | Buy |
12,800
+3,695
| +41% | +$112K | 0.01% | 656 |
|
|
2017
Q1 | $241K | Buy |
9,105
+716
| +9% | +$19K | 0.01% | 1128 |
|
|
2016
Q4 | $214K | Buy |
8,389
+1,631
| +24% | +$41.6K | 0.01% | 1175 |
|
|
2016
Q3 | $245K | Sell |
6,758
-7,382
| -52% | -$268K | 0.01% | 1122 |
|
|
2016
Q2 | $480K | Buy |
14,140
+3,044
| +27% | +$103K | 0.01% | 722 |
|
|
2016
Q1 | $293K | Buy |
11,096
+6,660
| +150% | +$176K | 0.01% | 1085 |
|
|
2015
Q4 | $216K | Sell |
4,436
-4,033
| -48% | -$196K | 0.01% | 1260 |
|
|
2015
Q3 | $211K | Buy |
+8,469
| New | +$211K | 0.01% | 1250 |
|